Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country

被引:0
作者
Mueller, D. H. [1 ]
Mwenge, L. [2 ]
Muyoyeta, M. [2 ]
Muvwimi, M. W. [3 ]
Tembwe, R. [3 ]
McNerney, R. [4 ]
Godfrey-Faussett, P. [5 ]
Ayles, H. M. [2 ,5 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Econ & Financing Programme, London WC1E 7HT, England
[2] Zambia AIDS Related TB ZAMBART Project, Lusaka, Zambia
[3] Chest Dis Lab, Lusaka, Zambia
[4] Univ London London Sch Hyg & Trop Med, Pathogen Mol Biol Unit, London WC1E 7HT, England
[5] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1E 7HT, England
关键词
tuberculosis; cost-effectiveness; culture media; developing countries; Zambia;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
OBJECTIVES: To examine the cost and cost-effectiveness at the Zambian National TB Reference Laboratory of homemade and commercially produced Lowenstein-Jensen culture (HLJ and CLJ) as well as automated and manually read liquid culture (AMGIT and MMGIT). DESIGN: Costs were estimated from the provider's perspective and based on the average monthly throughput. Cost-effectiveness estimates were based on yield during the study period. RESULTS: All techniques show comparable costs per culture (between US$28 and $32). Costs per Mycobacterium tuberculosis specimen detected were respectively USS197, $202, $312 and $340 for MMGIT, AMGIT, CLJ and HLJ. When modelled for the maximum throughput, costs were above US$95 per M. tuberculosis specimen detected for all techniques. When only performed among smear-negative specimens, costs per additionally identified M. tuberculosis would be US$487 for MMGIT and higher for other methods. CONCLUSION: Based on cost-effectiveness grounds, liquid media compare well with conventional solid media, especially where yield of MGIT is substantially higher than that of LJ media. The results indicate high overall costs per culture; the expansion of culture to decentralised levels with lower throughputs may result in even higher costs.
引用
收藏
页码:1196 / 1202
页数:7
相关论文
共 35 条
[21]  
MWEEMBA MW, 2005, CHEST DIS LAB ANN RE
[22]  
Needham DM, 1998, INT J TUBERC LUNG D, V2, P811
[23]   Fully automated liquid culture system compared with Lowenstein-Jensen solid medium for rapid recovery of Mycobacteria from clinical samples [J].
Palacios J.J. ;
Ferro J. ;
Ruiz Palma N. ;
García J.M. ;
Villar H. ;
Rodríguez J. ;
Macías M.D. ;
Prendes P. .
European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 (4) :265-273
[24]   Progress towards improved tuberculosis diagnostics for developing countries [J].
Perkins, MD ;
Roscigno, G ;
Zumla, A .
LANCET, 2006, 367 (9514) :942-943
[25]  
Perkins MD, 2006, INT J TUBERC LUNG D, V10, P1
[26]   Comparison of the Bactec 460TB system and the Bactec MGIT 960 system in recovery of mycobacteria from clinical specimens [J].
Pinheiro, MD ;
Ribeiro, MM .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (03) :171-173
[27]   WHO's new Stop TB Strategy [J].
Raviglione, MC ;
Uplekar, MW .
LANCET, 2006, 367 (9514) :952-955
[28]   Worldwide emergence of extensively drug-resistant tuberculosis [J].
Shah, N. Sarita ;
Wright, Abigail ;
Bai, Gill-Han ;
Barrera, Lucia ;
Boulahbal, Fadila ;
Martin-Casabona, Nuria ;
Drobniewski, Francis ;
Gilpin, Chris ;
Havelkova, Marta ;
Lepe, Rosario ;
Lumb, Richard ;
Metchock, Beverly ;
Portaels, Francoise ;
Rodrigues, Maria Filomena ;
Ruesch-Gerdes, Sabine ;
Van Deun, Armand ;
Vincent, Veronique ;
Laserson, Kayla ;
Wells, Charles ;
Cegielski, J. Peter .
EMERGING INFECTIOUS DISEASES, 2007, 13 (03) :380-387
[29]  
Somoskövi A, 1999, J CLIN MICROBIOL, V37, P1366
[30]  
Somoskövi A, 2000, J CLIN MICROBIOL, V38, P2395